The effect of exercise modality and intensity on Interleukin-6 (IL-6), iron status, and hepcidin levels was investigated. Ten trained male triathletes performed 4 exercise trials including low-intensity continuous running (L-R), low-intensity continuous cycling (L-C), high-intensity interval running (H-R), and high-intensity interval cycling (H-C). Both L-R and L-C consisted of 40 min continuous exercise performed at 65% of peak running velocity (vVO2peak) and cycling power output (pVO2peak), while H-R and H-C consisted of 8 × 3-min intervals performed at 85% vVO2peak and pVO2peak. Venous blood samples were drawn pre-, post-, and 3 hr postexercise. Significant increases in postexercise IL-6 were seen within each trial (p < .05) and were significantly greater in H-R than L-R (p < .05). Hepcidin levels were significantly elevated at 3 hr postexercise within each trial (p < .05). Serum iron levels were significantly elevated (p < .05) immediately postexercise in all trials except L-C. These results suggest that, regardless of exercise mode or intensity, postexercise increases in IL-6 may be expected, likely influencing a subsequent elevation in hepcidin. Regardless, the lack of change in postexercise serum iron levels in L-C may indicate that reduced hemolysis occurs during weight-supported, low-intensity activity.
Marc Sim, Brian Dawson, Grant Landers, Dorine W. Swinkels, Harold Tjalsma, Debbie Trinder and Peter Peeling
Mary P. Miles, Erin E. Walker, Stephen B. Conant, Shelly P. Hogan and Jessy R. Kidd
Attenuation of exercise-induced interleukin-6 (IL-6) responses by carbohydrate (CHO) has been demonstrated in studies comparing controlled doses (≥ 0.9 g · kg−1 · h−1) to placebo, but not in studies of voluntary intake. This study sought to determine if attenuation of the IL-6 response during a 32.2-km mountain trail race occurs for high compared to low ad libitum CHO intakes. IL-6, C-reactive protein (CRP), and creatine kinase activity (CK) were analyzed from blood samples collected 12 h pre-, 0, 4, and 24 h post-race. Subjects were grouped into low (n = 14, 0.4 ± 0.1 g · kg−1· h−1) and high (n = 18, 0.8 ± 0.2 g · kg−1 · h−1) CHO intake groups. IL-6 0 h post-race (P < 0.05) was higher in the low (40.2 ± 22.7 pg · mL−1) compared to the high CHO group (32.7 ± 22.1 pg · mL−1). CRP and CK both increased post-race, but no differences were observed between groups. Attenuation of exercise-induced IL-6 is apparent across a range of CHO intakes.
Elaine M. Murtagh, Colin Boreham, Alan Nevill, Gareth Davison, Tom Trinick, Ellie Duly, Mawloud El-Agnaf and Marie H. Murphy
Markers of inflammation are emerging as novel indices of cardiovascular risk. These markers have been shown to alter acutely after intense exercise; however, the effects of more moderate intensity exercise in healthy individuals is not known. Walking forms a cornerstone of physical activity promotion, so the inflammatory response to this exercise merits investigation. This study evaluated the effects of a 45-min walk on C-reactive protein (CRP) and interleukin 6 (IL-6), in sedentary, overweight men.
Fifteen men (49.7 ± 5.9 y) walked for 45 min at 60 to 70% of predicted maximum heart rate. Fasted blood samples were taken prior to and immediately 1 hr and 24 h post-walk.
IL-6 decreased from 1 h post-walk to 24 h post-walk (P < 0.01). No significant changes were observed in CRP.
These findings suggest that 45 min walking at 60 to 70% HRmax-p causes a decrease in IL-6 24 h post-exercise, but does not evoke a significant response in CRP levels.
Mary P. Miles, Sherri D. Pearson, Jan M. Andring, Jessy R. Kidd and Stella L. Volpe
The purpose of this investigation was to determine whether carbohydrate supplementation during the frst 2 d post exercise recovery influenced the inflammation (IL-6, C-reactive protein [CRP], and cortisol) and muscle-damage responses. Eight participants performed a high-force eccentric elbow-fexion exercise to induce muscle soreness and inflammation and then consumed carbohydrate (0.25 g·kg−1·h−1) or an equal volume of placebo during hours 0–12 and 24–36 post exercise in a double-blind, crossover protocol. Muscle soreness; mid brachial arm circumference; blood glucose, IL-6, CRP, cortisol, and creatine-kinase (CK) activity; and maximal force production were measured pre exercise and 4, 8, 12, 24, 48, and 120 h post exercise. Plasma IL-6 increased, F(5) = 5.27, P < 0.05, 8 h post exercise, with no difference between carbohydrate and placebo conditions. Changes in muscle soreness, arm circumference, strength, and serum CK activity were consistent with small amounts of muscle damage and did not differ between conditions. The authors conclude that carbohydrate supplementation during recovery from soreness-inducing exercise does not influence the delayed IL-6 response temporally linked to inflammation or indications of muscle damage. Thus, increased carbohydrate consumption at levels consistent with recommendations for replenishing glycogen stores does not impair or promote the immune and muscle responses.
Paula Robson-Ansley, Martin Barwood, Clare Eglin and Les Ansley
Fatigue is a predictable outcome of prolonged physical activity; yet its biological cause remains uncertain. During exercise, a polypeptide messenger molecule inter-leukin-6 (IL-6) is actively produced. Previously, it has been demonstrated that administration of recombinant IL-6 (rhIL-6) impairs 10-km run performance and heightened sensation of fatigue in trained runners. Both high carbohydrate diets and carbohydrate ingestion during prolonged exercise have a blunting effect on IL-6 levels post endurance exercise. We hypothesized that carbohydrate ingestion may improve performance during a prolonged bout of exercise as a consequence of a blunted IL-6 response. Seven recreationally trained fasted runners completed two 90-min time trials under CHO supplemented and placebo conditions in a randomized order. The study was of a double-blinded, placebo-controlled, cross-over study design. Distance covered in 90 min was significantly greater following exogenous carbohydrate ingestion compared with the placebo trial (19.13 ± 1.7 km and 18.29 ± 1.9 km, respectively, p = .0022). While post exercise IL-6 levels were significantly lower in the CHO trial compared with the placebo trial (5.3 ± 1.9 pg·mL−1 and 6.6 ± 3.0 pg·mL−1, respectively; p = .0313), this difference was considered physiologically too small to mediate the improvement in time trial performance.
Yasmeen Mezil, J. Obeid, Sandeep Raha, Thomas J. Hawke and Brian W. Timmons
environment that closely interact with muscle and bone ( 20 , 27 ). Effects of systemic factors that are known to increase with exercise have recently been studied in relation to muscle and bone adaptations using in vivo and in vitro models ( 9 , 16 , 19 , 27 ). Interleukin-6 (IL-6), one of the most
Francisco Tavares, Martyn Beaven, Júlia Teles, Dane Baker, Phil Healey, Tiaki B. Smith and Matthew Driller
, µL Day (1, 17) 0.055 .055 Group (1, 17) 2.845 .110 Day × group (1, 17) 0.232 .636 Cortisol, µL Day (1, 16) 0.055 .483 Group (1, 16) 2.845 .882 Day × group (1, 16) 0.232 .337 Abbreviations: AU, arbitrary units; CON, control; CMJ, countermovement jump; CWI, cold-water immersion; IL-6, interleukin-6; LB
Stephen M. Cornish, Jeremie E. Chase, Eric M. Bugera and Gordon G. Giesbrecht
, & Harafuji, 2014 ) that have various effects on metabolism and cell signaling. Myokines such as interleukin-6 (IL-6) have shown some potential to act on skeletal muscle as part of the hypertrophy process ( Peake, Nosaka, Muthalib, & Suzuki, 2015 ). Specifically, IL-6 is involved in satellite cell signaling
Alannah K. A. McKay, Ida A. Heikura, Louise M. Burke, Peter Peeling, David B. Pyne, Rachel P.L. van Swelm, Coby M. Laarakkers and Gregory R. Cox
concentrations of the inflammatory cytokine interleukin-6 (IL-6) ( Hennigar et al., 2017 ), which may have downstream implications for the iron-regulatory hormone hepcidin ( Badenhorst et al., 2015 ). Adherence to a low-CHO diet (3 g/kg) for 24 hr can amplify the immediate postexercise IL-6 and the 3-hr
Bindu P. Gopalan, Mary Dias, Karthika Arumugam, Reena R. D’Souza, Mathew Perumpil, Prasanna Kulkarni, Udaykumar Ranga and Anita Shet
Inflammation Pro and anti-inflammatory cytokines including tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), interferon gamma (IFNγ), and interleukin-10 (IL-10) were measured in the stored frozen plasma at Y0 and Y2 using the enzyme-linked immunosorbent assay according to the manufacturer’s protocol